Lipocine Stock Analysis

Lipocine Stock Analysis Notes

The company has price-to-book ratio of 1.32. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Lipocine recorded a loss per share of 0.75. The entity had not issued any dividends in recent years. The firm had 1:17 split on the 12th of May 2023. Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The companys pipeline candidates also include LPCN 1144, an oral prodrug of bioidentical testosterone that has completed Phase II clinical trial for the treatment of non-cirrhotic non-alcoholic steatohepatitis LPCN 1111, an oral prodrug of testosterone tridecanoate for once daily dosing, which has completed Phase II clinical trial in hypogonadal men LPCN 1148, a novel prodrug of testosterone and testosterone laurate for the management of decompensated cirrhosis LPCN 1154, an investigational new drug application to conduct a Phase 2 study in Postpartum depression LPCN 2101 for women with epilepsy, which has completed pre-clinical study and LPCN 1107, an oral hydroxyprogesterone caproate product that has completed dose finding Phase II clinical trial for the prevention of recurrent preterm birth To find out more about Lipocine contact Mahesh Patel at 801 994 7383 or learn more at https://www.lipocine.com.

Lipocine Investment Alerts

Lipocine Upcoming and Recent Events

Lipocine Largest EPS Surprises

View All Earnings Estimates

Lipocine Environmental, Social, and Governance (ESG) Scores

Lipocine Thematic Classifications

Lipocine Stock Institutional Investors

Note, although Lipocine's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Lipocine Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 25.19 M.

Lipocine Profitablity

The company has Profit Margin (PM) of (1.77) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (36.76) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $36.76.

Management Efficiency

Lipocine has return on total asset (ROA) of (0.2267) % which means that it has lost $0.2267 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3412) %, meaning that it created substantial loss on money invested by shareholders. Lipocine's management efficiency ratios could be used to measure how well Lipocine manages its routine affairs as well as how well it operates its assets and liabilities. As of the 21st of November 2024, Return On Tangible Assets is likely to grow to -0.68. In addition to that, Return On Capital Employed is likely to drop to -0.92. At this time, Lipocine's Total Assets are very stable compared to the past year. As of the 21st of November 2024, Other Assets is likely to grow to about 4 M, while Net Tangible Assets are likely to drop about 27 M.

Technical Drivers

As of the 21st of November, Lipocine secures the Mean Deviation of 3.29, downside deviation of 4.28, and Risk Adjusted Performance of 0.0906. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Lipocine, as well as the relationship between them.

Lipocine Price Movement Analysis

Lipocine Insider Trading Activities

Lipocine Outstanding Bonds

Lipocine Predictive Daily Indicators

Lipocine Corporate Filings

Lipocine Forecast Models

Lipocine's time-series forecasting models are one of many Lipocine's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Lipocine's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Lipocine prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Lipocine shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Lipocine. By using and applying Lipocine Stock analysis, traders can create a robust methodology for identifying Lipocine entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Lipocine analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Lipocine analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Lipocine stock analysis indicators help investors evaluate how Lipocine stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Lipocine shares will generate the highest return on investment. By understating and applying Lipocine stock analysis, traders can identify Lipocine position entry and exit signals to maximize returns.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lipocine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipocine. If investors know Lipocine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipocine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Lipocine is measured differently than its book value, which is the value of Lipocine that is recorded on the company's balance sheet. Investors also form their own opinion of Lipocine's value that differs from its market value or its book value, called intrinsic value, which is Lipocine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipocine's market value can be influenced by many factors that don't directly affect Lipocine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Lipocine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lipocine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipocine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.